Get the Stockscreener App
0.045
43.00%
-0.055
Vincerx Pharma Inc stock is traded at $0.045, with a volume of 387.78K.
It is down -43.00% in the last 24 hours and down -89.43% over the past month.
See More
Previous Close:
$0.10
Open:
$0.0418
24h Volume:
387.78K
Relative Volume:
5,091.16
Market Cap:
$N/A
Revenue:
-
Net Income/Loss:
$-48.85M
P/E Ratio:
-0.0195
EPS:
-2.31
Net Cash Flow:
$-46.25M
1W Performance:
-43.00%
1M Performance:
-89.43%
6M Performance:
-99.23%
1Y Performance:
-99.66%
1-Day Range:
$0.0418
$0.048
1-Week Range:
$0.0418
$0.048
52-Week Range:
$0.0418
$0.048
Vincerx Pharma Inc Stock (VINC) Company Profile
Compare VINC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
VINC
Vincerx Pharma Inc
|
0.045 | 0 | 0 | -48.85M | -46.25M | -2.31 |
|
VRTX
Vertex Pharmaceuticals Inc
|
466.36 | 115.95B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
547.75 | 56.52B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
317.50 | 39.44B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
538.64 | 35.14B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
244.47 | 28.51B | 3.81B | -644.79M | -669.77M | -6.24 |
Vincerx Pharma Inc Stock (VINC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-14-22 | Initiated | H.C. Wainwright | Buy |
| Dec-23-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-01-21 | Initiated | SVB Leerink | Outperform |
| Sep-13-21 | Initiated | Laidlaw | Buy |
| Aug-25-21 | Initiated | B. Riley Securities | Buy |
Vincerx Pharma Inc Stock (VINC) Latest News
Vincerx Pharma, Inc. Announces Adjournment of Special MeetingWill Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution Proposal - GlobeNewswire
Vincerx Pharma Stockholders Risk Losing All Distribution Value if Dissolution Vote Fails by July 16 - Stock Titan
At a crossroads, biotechs are passing on reverse mergers in 2025 - Endpoints News
Layoff Tracker: IGM Axes 80% of Workforce - BioSpace
Stock Market Recap: Vincerx Pharma Inc (VINC) Concludes at 0.26, a 1.11 Surge/Decline - DWinneX
Investing in Vincerx Pharma Inc [VINC]: What You Must Know - knoxdaily.com
Post-Trade Analysis: Vincerx Pharma Inc (VINC) Slides -24.98, Closing at 0.10 - DWinneX
Vincerx Pharma Inc (VINC) Stock: From Low to High in 52 Weeks - investchronicle.com
Why Vincerx Pharma Inc Stock Might Make Sense If Bought Today - Stocksregister
Vincerx Pharma Stock Price, Quotes and Forecasts | NASDAQ:VINC - Benzinga
The Vincerx Pharma Inc (VINC) Stock Is Headed for a Correction - uspostnews.com
VINC stock touches 52-week low at $0.17 amid sharp annual decline By Investing.com - Investing.com South Africa
VINC stock touches 52-week low at $0.17 amid sharp annual decline - Investing.com India
Nasdaq to delist Vincerx Pharma by April 23 By Investing.com - Investing.com South Africa
Nasdaq to delist Vincerx Pharma by April 23 - Investing.com India
Finance Watch: Investors Push ESSA Pharma, Elevation Oncology To Wind Down - insights.citeline.com
Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC - TradingView
Vincerx Pharma announces plan to delist from Nasdaq - TipRanks
Vincerx Pharma Announces Suspension and Intent to Delist Common Stock from Nasdaq - Nasdaq
Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - GlobeNewswire
Vincerx Pharma Announces Complete Liquidation and Nasdaq Exit: What Happens to Your Shares? - Stock Titan
Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer - GlobeNewswire
Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Expands By 99.4% - Defense World
Short Interest in Vincerx Pharma, Inc. (NASDAQ:VINC) Increases By 99.4% - The AM Reporter
vincerx pharma cancels merger, initiates wind-down activities - Investing.com Australia
vincerx pharma cancels merger, initiates wind-down activities By Investing.com - Investing.com India
Vincerx Pharma Inc Initiates Wind Down and Asset Monetization - TipRanks
VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles By Investing.com - Investing.com South Africa
VINC Stock Touches 52-Week Low at $0.27 Amid Market Struggles - Investing.com
Pre-market Movers: VERO, WORX, QLGN, VINC... - RTTNews
US Stocks Futures Trade Mixed Ahead Of Opening Bell: 'Preserve Capital In Conditions Of High Uncertainty,' Says Expert - Benzinga
Vincerx Pharma ends merger talks, begins asset wind-down By Investing.com - Investing.com Canada
Financially struggling drugmaker's potential rescue falls apart. It now will wind downSan Francisco Business Times - The Business Journals
Vincerx terminates letter of intent with Global Digital, initiates wind down - TipRanks
Vincerx Pharma ends merger talks, begins asset wind-down - Investing.com
Vincerx Pharma Announces Termination of Letter of Intent and Board Authorization to Pursue Wind-Down Activities - The Manila Times
Vincerx Pharma Begins Wind-Down After Terminating Merger Plan With QumulusAI - marketscreener.com
Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities - MarketScreener
Failed Merger Forces Vincerx Pharma to Begin Company Wind-Down: What's Next for Investors? - Stock Titan
VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline - Investing.com
VINC Stock Plummets to 52-Week Low of $0.48 Amid Steep Decline By Investing.com - Investing.com South Africa
Vincerx Pharma (VINC) Projected to Post Quarterly Earnings on Friday - Defense World
Vincerx Pharma Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Vincerx Pharma Inc Stock (VINC) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.56%
0.22%
Cap:
|
Volume (24h):